Slide 1Updates on Breast Diseases: What clinicians need to know from pathologists Preah Bat Norodom Sihanouk Hopsital, 22 April 2009 Monirath Hav, MD, Ph.D. fellow (VLIR…

1.PERJETA® is a first-line treatment for HER2positive metastatic breast cancer. • PERJETA is an FDA-approved treatment for HER2-positive metastatic breast cancer. It is…

1. G-protein coupled receptors 7-pass transmemb proteinsGPCRs: largest fam cell surface receptors (>700 in humans), wide variety sig mlcs can activate GPCRs 50% known…

www.eurofins.com Product Characterization, PK and Immunogenicity Assays for the Development of Biosimilar Trastuzumab John Kamerud, Ph.D. Scientific Director Eurofins Bioanalytical…

Adjuvant systemic therapy Breast cancer Survival after early breast cancer Survival in BC: Best in Canada and similar to Australia, Sweden Improvements over time: adjuvant…

Slide 1 Anna Long and Judith Hogarth Cellular Pathology Newcastle upon Tyne Hospitals NHS Foundation Trust North of England Cancer Network HER2 testing Audit Slide 2 We will…